Physician profile
Fernand N Parent
NPI 1700974649
$1,189.31
in general payments reported to CMS, 2019-2025
11 companies · $21.13 in 2025
The $21.13 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.59 · 2020: $155 · 2021: $351 · 2022: $351 · 2023: $174 · 2024: $124 · 2025: $21.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $216.87 | 2022-2024 | Xarelto |
| Esperion Therapeutics, INC. | $205.91 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $184.07 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $124.74 | 2021 | |
| Lilly USA, LLC | $105.43 | 2020-2023 | Mounjaro |
| E.R. Squibb & Sons, L.L.C. | $89.62 | 2022 | |
| Amgen INC. | $83.16 | 2023 | Repatha |
| Novo Nordisk INC | $78.38 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $68.41 | 2022 | |
| Amneal Pharmaceuticals LLC | $21.13 | 2025 | Unithroid |
| Advanced Respiratory, INC | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernand Parent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.